Analysts Viewpoint
Beam Therapeutics Inc (BEAM) Becoming More Attractive for Investors
Beam Therapeutics Inc’s recently made public that its Chief Medical Officer Simon Amy unloaded Company’s shares for reported $17625.0 on
Menu
Beam Therapeutics Inc’s recently made public that its Chief Medical Officer Simon Amy unloaded Company’s shares for reported $17625.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Beam Therapeutics
In a filing, Beam Therapeutics Inc revealed its Chief Medical Officer Simon Amy unloaded Company’s shares for reported $17625.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Beam Therapeutics Inc’s recently made public that its Chief Medical Officer Simon Amy unloaded Company’s shares for reported $17625.0 on
Beam Therapeutics Inc’s filing revealed that its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Beam Therapeutics Inc’s recently made public that its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million